Samsung Electronics Denies Takeover Of Israeli Medical Device Maker OrSense
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Samsung Electronics denied a local newspaper report June 2 that it is seeking to buy Israeli medical device maker OrSense Ltd.
You may also be interested in...
Samsung Biologics Takes First Step In The CMO Business While Targeting Innovative Compounds By 2017
INCHEON, South Korea - Samsung Biologics entered the first stage of a plan to become a global biopharmaceutical company, breaking ground on a biologics manufacturing plant May 27. The company hopes to establish itself as a global contract manufacturer before entering the biosimilar sector with its first entrant, a biosimilar of the monoclonal antibody Rituxan (rituximab)
Financings In Brief
Device VC activity increases
Samsung Electronics Takes Over Leading Medical Device Maker Medison
SEOUL - South Korea's Samsung Electronics is further building its burgeoning presence in the healthcare sector through the takeover of the country's leading medical equipment maker Medison Co. from a private equity fund